Abstract

O1-8-3 - TAS-102 in patients with metastatic colorectal cancer refractory to standard therapies including regorafenib

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study.
Matteo Conti ... Giovambattista Roda’
Cancers | VOL. 15
Matteo Conti, et. al.Matteo Conti ... Giovambattista Roda’
02 Jul 2023
P-284 Phase 3 RECOURSE trial of TAS-102 versus placebo with best supportive care in patients with metastatic colorectal cancer: European subgroup
A Falcone ... E Van Cutsem
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 26
A Falcone, et. al.A Falcone ... E Van Cutsem
01 Jun 2015
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer
Jeremy Chuang ... Marwan Fakih
Clinical colorectal cancer | VOL. 21
Jeremy Chuang, et. al.Jeremy Chuang ... Marwan Fakih
23 May 2022
A phase I/II study for panitumumab combined with TAS-102 in patients with RAS wild-type metastatic colorectal cancer (APOLLON study): Phase I results.
Takeshi Kato ... Koji Oba
Journal of Clinical Oncology | VOL. 35
Takeshi Kato, et. al.Takeshi Kato ... Koji Oba
01 Feb 2017
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia
B Eichhorst ... C Buske
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
B Eichhorst, et. al.B Eichhorst ... C Buske
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers